$32.52
-1.68-4.91%
Last update: Nov 6, 4:42 PM
Castle Biosciences Inc (CSTL) Stock Price, Quote, News & History
CSTLNASDAQ
Castle Biosciences (NASDAQ:CSTL) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Castle Biosciences (NASDAQ:CSTL) through any online brokerage.
Other companies in Castle Biosciences’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Quest Diagnostics Inc (NYSE:DGX) and Guardant Health Inc (NASDAQ:GH).
Castle Biosciences has a consensus price target of $42.70.
The stock price for Castle Biosciences (NASDAQ: CSTL) is $32.52 last updated November 6, 2026 at 4:42 PM EST.
There are no upcoming dividends for Castle Biosciences.
Castle Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Castle Biosciences.
Castle Biosciences is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes...
